Multiple sclerosis drugs on Blue Rx PDP Plus (S5593-002)
Kesimpta, teriflunomide, dimethyl fumarate and the other MS drugs Part D covers, checked against this plan's 2026 formulary (its list of covered drugs).
- Plan type
- Stand-alone drug plan (PDP), Pennsylvania + 1 more
- Premium
- $193.20/month
- Deductible
- $615.00
6 of 8 Multiple sclerosis drugs are covered on this plan. All 6 require prior authorization.
2 aren't on the formulary (Mayzent and Mavenclad).
- $2,409.73Tier 5
- from $297.98Tier 5
- from $74.55Tier 4
- $2,117.18Tier 5
- $555.30Tier 5
- from $77.44Tier 5
Not on the formulary
Mayzent, Mavenclad
Patient cost for a 30-day supply at a preferred retail pharmacy, after the $615.00 deductible where it applies. Where the plan charges a percentage (coinsurance), the dollar figure is that share of the plan's negotiated price; "from" means other strengths cost more. Data from the CMS 2026 Part D formulary and pricing files.